Treatt PLC (GB:TET)
LSE:TET
Want to see GB:TET full AI Analyst Report?
Top Page
Treatt plc
(LSE:TET)
Select Model
Select Model
Rating:64Neutral
Price Target:
320.00 p
▲(50.59% Upside)
Action:Reiterated
Date:05/01/26
The score is driven mainly by mixed financial performance: a very strong, low-leverage balance sheet offsets a notable FY2025 profitability reset and weaker/volatile free cash flow. Technicals are supportive due to a strong uptrend, but the very high RSI increases near-term reversal risk. Valuation is a headwind given the high P/E and only modest dividend yield.
Positive Factors
Low leverage / strong balance sheet
Very low debt-to-equity (~0.06) gives Treatt durable financial flexibility to fund working-capital swings, sustain operations through demand cycles, and invest selectively without needing external financing, supporting long-term resilience and strategic optionality.
Negative Factors
Profitability reset (FY2025)
A sharp margin and revenue decline in FY2025 indicates structural pressures—mix, pricing, or cost inflation—that materially erode returns on capital. Persistently lower margins would shrink reinvestment capacity and weaken long-term profitability even if volumes stabilise.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong balance sheet
Very low debt-to-equity (~0.06) gives Treatt durable financial flexibility to fund working-capital swings, sustain operations through demand cycles, and invest selectively without needing external financing, supporting long-term resilience and strategic optionality.
Read all positive factors
Treatt plc (TET) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£177.72M
Dividend Yield4.08%
Average Volume (3M)863.87K
Price to Earnings (P/E)19.8
Beta (1Y)0.68
Revenue Growth-11.72%
EPS Growth-60.87%
CountryUK
Employees379
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)0.07
Shares Outstanding59,043,186
10 Day Avg. Volume910,892
30 Day Avg. Volume863,865
Financial Highlights & Ratios
PEG Ratio-0.49
Price to Book (P/B)1.20
Price to Sales (P/S)1.23
P/FCF Ratio27.33
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£242.50Price Target Upside14.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.13
Revenue Forecast (FY)£136.14M
Treatt plc Business Overview & Revenue Model
Company Description
Treatt plc, together with its subsidiaries, manufactures and supplies various natural extracts and ingredients to the flavor, fragrance, beverage, and consumer product industries in the United Kingdom, Germany, Ireland, the United States, China, a...
How the Company Makes Money
Treatt makes money primarily by manufacturing and selling specialty ingredients to food and beverage producers. Its revenue model is largely B2B ingredient sales, where customers purchase Treatt’s extracts, distillates, and flavor/aroma ingredient...
Treatt plc Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
84
Very Positive
Cash Flow
55
Neutral
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 128.15M | 132.47M | 153.07M | 147.40M | 140.19M | 124.33M |
| Gross Profit | 32.48M | 33.80M | 44.49M | 44.82M | 39.08M | 42.22M |
| EBITDA | 12.03M | 13.15M | 24.22M | 19.31M | 19.05M | 21.52M |
| Net Income | 4.36M | 5.06M | 14.40M | 10.94M | 13.31M | 15.15M |
Balance Sheet | ||||||
| Total Assets | 168.67M | 168.59M | 169.85M | 175.02M | 188.18M | 149.42M |
| Cash, Cash Equivalents and Short-Term Investments | 1.91M | 1.75M | 1.79M | 809.00K | 2.35M | 7.26M |
| Total Debt | 6.31M | 8.37M | 2.52M | 11.19M | 24.77M | 16.37M |
| Total Liabilities | 32.65M | 33.85M | 27.84M | 37.77M | 54.33M | 43.12M |
| Stockholders Equity | 136.01M | 134.74M | 142.01M | 137.25M | 133.85M | 106.30M |
Cash Flow | ||||||
| Free Cash Flow | 1.29M | 5.94M | 15.40M | 15.78M | -14.16M | -5.80M |
| Operating Cash Flow | 5.07M | 10.67M | 21.07M | 21.49M | -1.39M | 8.57M |
| Investing Cash Flow | -3.89M | -4.97M | -5.63M | -4.16M | -7.17M | -14.36M |
| Financing Cash Flow | -1.79M | -5.67M | -14.37M | -12.51M | 4.38M | 963.00K |
Treatt plc Technical Analysis
Positive
212.50
Price Trends
235.47
Positive
221.75
Positive
227.07
Positive
Market Momentum
20.17
Positive
82.57
Negative
65.08
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:TET, the sentiment is Positive. The current price of 212.5 is below the 20-day moving average (MA) of 285.98, below the 50-day MA of 235.47, and below the 200-day MA of 227.07, indicating a bullish trend. The MACD of 20.17 indicates Positive momentum. The RSI at 82.57 is Negative, neither overbought nor oversold. The STOCH value of 65.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:TET.
Treatt plc Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | £4.00B | 1,203.12 | 2.82% | 3.45% | 4.38% | -60.87% | |
64 Neutral | £177.72M | 19.78 | 3.22% | 4.08% | -11.72% | -60.87% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | £846.31M | 16.15 | -6.85% | 1.34% | -21.51% | 7.34% | |
49 Neutral | £164.27M | -0.66 | -16.66% | ― | -12.46% | -116.21% | |
46 Neutral | £239.90M | 38.33 | 0.79% | 2.44% | -0.13% | -82.00% | |
43 Neutral | £13.82M | -3.72 | -19.63% | ― | 56.59% | 28.78% |
* Basic Materials Sector Average
GB:TET
Treatt plc
301.00
28.07
10.28%
GB:CRDA
Croda International
2,991.00
59.58
2.03%
GB:ELM
Elementis
150.80
23.48
18.45%
GB:ESNT
Essentra
86.50
-8.12
-8.58%
GB:ITX
Itaconix
105.00
5.00
5.00%
GB:SYNT
Synthomer
106.80
7.30
7.34%
Treatt plc Corporate Events
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Treatt Half-Year Profits Fall as Citrus Softens but Döhler Bid Emerges
Negative
Apr 29, 2026
Treatt reported a 6.5% decline in half-year revenue to £59.9m and a one-third drop in profit before tax and exceptionals to £2.5m, as citrus headwinds and softer Heritage and Premium volumes weighed on performance, although margins stabi...
Business Operations and StrategyExecutive/Board Changes
Treatt strengthens board with new independent directors and committee reshuffle
Positive
Apr 7, 2026
Treatt plc, a specialist in natural extracts and ingredients for the beverage, flavour and fragrance industries, has expanded its board with the appointment of Sangita Shah and Shaun Smith as independent non-executive directors. Shah, an experienc...
Business Operations and StrategyStock BuybackDividendsShareholder Meetings
Treatt Wins Strong Shareholder Backing at 2026 AGM
Positive
Mar 26, 2026
Treatt plc reported that all resolutions at its annual general meeting on 26 March 2026 in London were duly passed on a poll, including approval of the annual report, the final dividend and the directors’ remuneration report. Shareholders al...
Business Operations and StrategyFinancial DisclosuresShareholder Meetings
Treatt signals improving H2 momentum and strong China growth in AGM update
Positive
Mar 26, 2026
Treatt reported that trading for the half year to 31 March 2026 has progressed as anticipated, with a seasonally quiet first quarter followed by growing momentum in the second quarter, underpinning confidence in meeting full-year expectations with...
Regulatory Filings and Compliance
Treatt Updates Total Voting Rights for Regulatory Disclosure Purposes
Neutral
Feb 19, 2026
Treatt plc has clarified that it has 61,283,093 ordinary shares in issue, but after excluding 1,793,543 treasury shares and 454,418 shares held in employee benefit and SIP trusts—on which voting rights are waived—the total number of vo...
Business Operations and StrategyExecutive/Board Changes
Treatt Confirms Randhawa as Permanent CFO and Adjusts Board Committees
Positive
Feb 12, 2026
Treatt plc, a specialist in natural extracts and ingredients for the beverage, flavour and fragrance markets, has strengthened its leadership team with the permanent appointment of Manprit Randhawa as Group Chief Financial Officer, effective 11 Fe...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.